TLR4 and head and neck squamous cell carcinoma: The negative association between the TLR4 Gly299 polymorphic allele and a poorer overall survival prognosis has also been reported in head and neck squamous cell carcinoma treated with systemic adjuvant therapies [61] and colon cancer treated with chemotherapy [62].